Levi & Korsinsky Investigates MoonLake Immunotherapeutics (MLTX) Over Potential Securities Fraud Allegations

NEW YORK CITY, NY / ACCESS Newswire / October 4, 2025 / NEW YORK, NY / ACCESS Newswire / October 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ:MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental

Investors in Dow Inc. (DOW): Protect Your Rights – Contact Levi & Korsinsky Before October 28, 2025

NEW YORK CITY, NY / ACCESS Newswire / October 4, 2025 / NEW YORK, NY / ACCESS Newswire / October 4, 2025 / If you suffered a loss on your Dow Inc. (NYSE:DOW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dow-inc-lawsuit-submission-form?prid=170803&wire=1&utm_campaign=11

Scroll to Top